Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Godavari Drugs Limited (GODAVARI.BO)

Compare
95.12
+1.60
+(1.71%)
At close: 3:29:08 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Mukund Kakani CEO, MD & Executive Director 1.8M -- 1952
Mr. Mohit Jaju CFO & Whole Time Director 1.8M -- 1971
Mr. Venkatesh Achanta Company Secretary & Compliance Officer -- -- --

Godavari Drugs Limited

1-8-303/34, Mayfair
1st Floor Sardar Patel Road
Secunderabad, 500003
India
91 40 2784 2602 https://godavaridrugs.com
Sector: 
Healthcare
Full Time Employees: 
111

Description

Godavari Drugs Limited manufactures and supplies active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan license and contract manufacturing services for API's and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was incorporated in 1987 and is based in Secunderabad, India.

Corporate Governance

Godavari Drugs Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 28, 2025 at 10:59 AM UTC - June 2, 2025 at 12:00 PM UTC

Godavari Drugs Limited Earnings Date

Recent Events

Related Tickers